MedPath

Grid Laser for Diffuse Diabetic Maculopathy

Completed
Conditions
Diabetic Macular Edema
Registration Number
NCT02555956
Lead Sponsor
Dow University of Health Sciences
Brief Summary

Diabetic related complications are increasing day by day due to increse in the number of diabetic patients all over the world. Diabetic macular edema is one of them and a major cause of vision imparment. Various kind of treatment modalities are preent to treat this coplication. Grid laser is one treatment modality. Laser phtocoagulation is a destrictive procedure.Laser power if kept to aminimum can get the desired results without severe destruction to the retina . In this study, the investigators are going to document the effect of minimal grid laser tn loss o overcome the visioe to diabetic macular edema.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Diabetic patients with macular edema.
  • both sexes
  • conset to participate.
Exclusion Criteria
  • focal edema.
  • patients requiring only the focal laser.
  • patients with proferative diabetic retinopathy.
  • Patients with ischaemic maculopathy on fundus fluorescein angiography.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of visual acuity after grid laser6 week

Visual acuity will be mesured pre laser and 06 weeks post laser

Secondary Outcome Measures
NameTimeMethod
Complicationduring first six weeks after laser

Patiens willbe asked and examined for any potentiail anticipated complication.

Trial Locations

Locations (1)

Dow universty Hospital,Dow international Medical college

🇵🇰

Karachi, Sindh, Pakistan

© Copyright 2025. All Rights Reserved by MedPath